Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Transbronchial biopsy needle rinse solution used for comprehensive biomarker testing in patients with lung cancer.

Sakairi Y, Sato K, Itoga S, Saegusa F, Matsushita K, Nakajima T, Yoshida S, Takiguchi Y, Nomura F, Yoshino I.

J Thorac Oncol. 2014 Jan;9(1):26-32. doi: 10.1097/JTO.0000000000000024.

2.

Adequacy of lymph node transbronchial needle aspirates using convex probe endobronchial ultrasound for multiple tumor genotyping techniques in non-small-cell lung cancer.

Folch E, Yamaguchi N, VanderLaan PA, Kocher ON, Boucher DH, Goldstein MA, Huberman MS, Kent MS, Gangadharan SP, Costa DB, Majid A.

J Thorac Oncol. 2013 Nov;8(11):1438-1444. doi: 10.1097/JTO.0b013e3182a471a9.

3.

Detection of EML4-ALK fusion genes in a few cancer cells from transbronchial cytological specimens utilizing immediate cytology during bronchoscopy.

Kanaji N, Bandoh S, Ishii T, Tadokoro A, Watanabe N, Takahama T, Haba R, Imataki O, Dobashi H, Matsunaga T.

Lung Cancer. 2012 Aug;77(2):293-8. doi: 10.1016/j.lungcan.2012.03.018. Epub 2012 Apr 10.

PMID:
22494566
4.

EGFR mutational genotyping of liquid based cytology samples obtained via fine needle aspiration (FNA) at endobronchial ultrasound of non-small cell lung cancer (NSCLC).

Reynolds JP, Tubbs RR, Minca EC, MacNamara S, Almeida FA, Ma PC, Pennell NA, Cicenia JC.

Lung Cancer. 2014 Nov;86(2):158-63. doi: 10.1016/j.lungcan.2014.09.003. Epub 2014 Sep 22.

PMID:
25263855
5.

Detection of epidermal growth factor receptor mutation in transbronchial needle aspirates of non-small cell lung cancer.

Horiike A, Kimura H, Nishio K, Ohyanagi F, Satoh Y, Okumura S, Ishikawa Y, Nakagawa K, Horai T, Nishio M.

Chest. 2007 Jun;131(6):1628-34.

PMID:
17565015
6.

Assessment of epidermal growth factor receptor mutation by endobronchial ultrasound-guided transbronchial needle aspiration.

Nakajima T, Yasufuku K, Suzuki M, Hiroshima K, Kubo R, Mohammed S, Miyagi Y, Matsukuma S, Sekine Y, Fujisawa T.

Chest. 2007 Aug;132(2):597-602. Epub 2007 Jun 15.

PMID:
17573511
7.

The peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations in bronchoscopic cytological specimens of non-small cell lung cancer.

Yamada N, Oizumi S, Asahina H, Shinagawa N, Kikuchi E, Kikuchi J, Sakakibara-Konishi J, Tanaka T, Kobayashi K, Hagiwara K, Nishimura M.

Oncology. 2012;82(6):341-6. doi: 10.1159/000338327. Epub 2012 Jun 2.

PMID:
22677909
9.
10.

Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy.

Tsai TH, Yang CY, Ho CC, Liao WY, Jan IS, Chen KY, Wang JY, Ruan SY, Yu CJ, Yang JC, Yang PC, Shih JY.

Lung Cancer. 2013 Dec;82(3):420-5. doi: 10.1016/j.lungcan.2013.10.005. Epub 2013 Oct 14.

PMID:
24183104
11.

Feasibility and accuracy of molecular testing in specimens obtained with small biopsy forceps: comparison with the results of surgical specimens.

Oki M, Yatabe Y, Saka H, Kitagawa C, Kogure Y, Ichihara S, Moritani S.

Respiration. 2015;89(3):235-42. doi: 10.1159/000369860. Epub 2015 Feb 11.

12.

A novel point-of-care system for high-speed real-time polymerase chain reaction testing for epidermal growth factor receptor mutations in bronchial lavage fluids after transbronchial biopsy in patients with non-small cell lung cancer.

Sakamoto T, Kodani M, Takata M, Chikumi H, Nakamoto M, Nishii-Ito S, Ueda Y, Izumi H, Makino H, Touge H, Takeda K, Yamasaki A, Yanai M, Tanaka N, Igishi T, Shimizu E.

Int J Oncol. 2015 Apr;46(4):1473-80. doi: 10.3892/ijo.2015.2875. Epub 2015 Feb 4.

13.

Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.

Nicholson AG, Gonzalez D, Shah P, Pynegar MJ, Deshmukh M, Rice A, Popat S.

J Thorac Oncol. 2010 Apr;5(4):436-41. doi: 10.1097/JTO.0b013e3181c6ed9b.

14.
15.

Endobronchial ultrasound guided transbronchial needle aspiration.

Medford AR, Bennett JA, Free CM, Agrawal S.

Postgrad Med J. 2010 Feb;86(1012):106-15. doi: 10.1136/pgmj.2009.089391. Review.

PMID:
20145060
16.

Assessment of epidermal growth factor receptor and K-ras mutation status in cytological stained smears of non-small cell lung cancer patients: correlation with clinical outcomes.

Lozano MD, Zulueta JJ, Echeveste JI, Gúrpide A, Seijo LM, Martín-Algarra S, Del Barrio A, Pio R, Idoate MA, Labiano T, Perez-Gracia JL.

Oncologist. 2011;16(6):877-85. doi: 10.1634/theoncologist.2010-0155. Epub 2011 May 14.

17.

Molecular alterations in non-small-cell lung cancer: perspective for targeted therapy and specimen management for the bronchoscopist.

Czarnecka-Kujawa K, Yasufuku K.

Respirology. 2014 Nov;19(8):1117-25. doi: 10.1111/resp.12377. Review.

18.

Suitability of computed tomography-guided biopsy specimens for subtyping and genotyping of non-small-cell lung cancer.

Hsiao SH, Chung CL, Lee CM, Chen WY, Chou YT, Wu ZH, Chen YC, Lin SE.

Clin Lung Cancer. 2013 Nov;14(6):719-25. doi: 10.1016/j.cllc.2013.06.002. Epub 2013 Jul 25.

PMID:
23891241
19.

Early detection of lung cancer by molecular markers in endobronchial epithelial-lining fluid.

Kahn N, Meister M, Eberhardt R, Muley T, Schnabel PA, Bender C, Johannes M, Keitel D, Sültmann H, Herth FJ, Kuner R.

J Thorac Oncol. 2012 Jun;7(6):1001-8. doi: 10.1097/JTO.0b013e31824fe921.

20.

Outcomes of an Australian testing programme for epidermal growth factor receptor mutations in non-small cell lung cancer.

Peters MJ, Bowden JJ, Carpenter P, Lewis J, Solomon B.

Intern Med J. 2014 Jun;44(6):575-80. doi: 10.1111/imj.12449.

PMID:
24720523

Supplemental Content

Support Center